利用脑影像数据与个体化建模刻画耐药性癫痫的致痫网络
研究提出虚拟癫痫患者(VEP)流程,基于个体化全脑网络模型与机器学习估计致痫区网络(EZN),回顾性评估53例耐药性局灶性癫痫患者,VEP复现临床定义EZN的精确度为0.6,并在25例手术患者中显示无发作患者假发现率均值0.028低于非无发作患者均值0.407,目前正在EPINOV临床试验中评估。
要点
- VEP流程结合T1与弥散加权MRI构建个体化全脑网络模型,以立体脑电图记录优化参数估计EZN。
- 回顾性53例中VEP复现临床定义EZN的精确度为0.6,致痫区物理距离小。
- 25例手术患者中无发作者假发现率均值0.028,低于非无发作者的0.407。
核心结论
- VEP流程可利用个体化脑模型与机器学习估计致痫区网络并辅助手术策略,目前正在EPINOV临床试验中评估,预期纳入356例前瞻性癫痫患者。
研究设计与样本
- 研究为回顾性评估VEP流程,纳入53例耐药性局灶性癫痫患者,其中25例接受手术。
- 个体化全脑网络模型的结构骨架由解剖T1与弥散加权磁共振成像构建,每个网络节点配备数学动力学模型模拟癫痫活动。
- 采用贝叶斯推断方法,利用患者癫痫发作的功能性立体脑电图记录采样并优化个体化模型的关键参数,关键参数与个体化模型共同确定EZN。
- 个体化模型进一步通过虚拟手术预测手术干预结局。
主要发现
- VEP复现临床定义EZN的精确度为0.6,VEP识别的致痫区与临床定义EZN之间的物理距离小。
- 与25例手术患者切除脑区相比,VEP在无发作患者中的假发现率均值0.028,低于非无发作患者的均值0.407。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Precise estimates of epileptogenic zone networks (EZNs) are crucial for planning intervention strategies to treat drug-resistant focal epilepsy. Here, we present the virtual epileptic patient (VEP), a workflow that uses personalized brain models and machine learning methods to estimate EZNs and to aid surgical strategies. The structural scaffold of the patient-specific whole-brain network model is constructed from anatomical T1 and diffusion-weighted magnetic resonance imaging. Each network node is equipped with a mathematical dynamical model to simulate seizure activity. Bayesian inference methods sample and optimize key parameters of the personalized model using functional stereoelectroencephalography recordings of patients' seizures. These key parameters together with their personalized model determine a given patient's EZN. Personalized models were further used to predict the outcome of surgical intervention using virtual surgeries. We evaluated the VEP workflow retrospectively using 53 patients with drug-resistant focal epilepsy. VEPs reproduced the clinically defined EZNs with a precision of 0.6, where the physical distance between epileptogenic regions identified by VEP and the clinically defined EZNs was small. Compared with the resected brain regions of 25 patients who underwent surgery, VEP showed lower false discovery rates in seizure-free patients (mean, 0.028) than in non-seizure-free patients (mean, 0.407). VEP is now being evaluated in an ongoing clinical trial (EPINOV) with an expected 356 prospective patients with epilepsy.
引用
- Wang HE, Woodman M, Triebkorn P, et al. Delineating epileptogenic networks using brain imaging data and personalized modeling in drug-resistant epilepsy. Sci Transl Med. 2023. PMID: 36696482. doi:10.1126/scitranslmed.abp8982
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。